 Oppenheimer analystSteven Lichtmanmaintained aHoldrating on Helius Medical Technologies HSDTResearch Report today. The companys shares closed last Thursday at 0.26, close to its 52-week low of 0.25.According toTipRanks.com, Lichtman 